Cutera, Inc. (NASDAQ:CUTR) saw a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 442,800 shares, a drop of 8.9% from the June 15th total of 485,900 shares. Based on an average daily trading volume, of 114,700 shares, the short-interest ratio is presently 3.9 days. Approximately 3.3% of the company’s shares are short sold.

Cutera stock traded up $0.16 during midday trading on Tuesday, hitting $25.14. 86,200 shares of the company’s stock were exchanged, compared to its average volume of 172,185. The company has a current ratio of 1.66, a quick ratio of 1.09 and a debt-to-equity ratio of 0.20. Cutera has a 12 month low of $12.32 and a 12 month high of $41.50. The business’s 50-day moving average price is $21.47. The firm has a market cap of $345.67 million, a P/E ratio of -11.27 and a beta of 0.88.

Cutera (NASDAQ:CUTR) last issued its earnings results on Thursday, May 9th. The medical device company reported ($0.59) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.29) by ($0.30). Cutera had a negative return on equity of 65.62% and a negative net margin of 22.45%. The business had revenue of $36.00 million for the quarter, compared to the consensus estimate of $33.45 million. During the same quarter in the previous year, the company earned ($0.02) earnings per share. The firm’s revenue was up 5.6% on a year-over-year basis. As a group, sell-side analysts expect that Cutera will post -0.66 earnings per share for the current year.

Several research analysts recently commented on the stock. ValuEngine raised shares of Valmont Industries from a “sell” rating to a “hold” rating in a research note on Friday, July 12th. BidaskClub downgraded shares of Weyco Group from a “sell” rating to a “strong sell” rating in a research note on Saturday, July 13th. Finally, Zacks Investment Research raised shares of DLH from a “sell” rating to a “hold” rating in a research note on Tuesday, July 9th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. Cutera currently has an average rating of “Buy” and an average target price of $34.67.

In related news, Director J Daniel Plants purchased 28,166 shares of Cutera stock in a transaction that occurred on Monday, June 3rd. The shares were bought at an average price of $16.73 per share, with a total value of $471,217.18. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders purchased a total of 49,522 shares of company stock worth $832,825 in the last ninety days. 2.30% of the stock is currently owned by insiders.

Institutional investors have recently modified their holdings of the business. BNP Paribas Arbitrage SA grew its holdings in Cutera by 56,660.0% during the 1st quarter. BNP Paribas Arbitrage SA now owns 2,838 shares of the medical device company’s stock worth $50,000 after acquiring an additional 2,833 shares in the last quarter. Municipal Employees Retirement System of Michigan bought a new position in Cutera during the 4th quarter worth about $65,000. Metropolitan Life Insurance Co. NY grew its holdings in Cutera by 359.4% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 4,704 shares of the medical device company’s stock worth $80,000 after acquiring an additional 3,680 shares in the last quarter. Marshall Wace North America L.P. grew its holdings in Cutera by 41.3% during the 1st quarter. Marshall Wace North America L.P. now owns 5,052 shares of the medical device company’s stock worth $89,000 after acquiring an additional 1,476 shares in the last quarter. Finally, Bank of Montreal Can grew its holdings in Cutera by 53.9% during the 1st quarter. Bank of Montreal Can now owns 10,846 shares of the medical device company’s stock worth $192,000 after acquiring an additional 3,799 shares in the last quarter. Institutional investors own 92.47% of the company’s stock.

About Cutera

Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.

Read More: What are the advantages of the Stochastic Momentum Index?

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.